QuantHealth raised $45 million in Series B funding to expand its AI platform, which simulates clinical trials before they run and predicts patient outcomes for pharma companies. The startup is aiming to cut the industry’s 90% trial failure rate and speed up the timelines for effective drugs to reach the market.
The post QuantHealth Snags $45M to Simulate Clinical Trials Before Patients Ever Enroll appeared first on MedCity News.
Onshoring Is Here. The Hiring Wave Is Still a Decade Out
Guest Commentary Since 2025, pharmaceutical companies have committed more than $370 billion to build manufacturing in the United States—a response to the threat of steep
